Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
9.03
-0.02 (-0.22%)
Nov 3, 2026, 4:00 PM EST - Market closed
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.15 billion as of November 3, 2026. Its market cap has decreased by 11.35% in one year.
Market Cap
3.15B
Enterprise Value
3.48B
1-Year Change
-11.35%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.15B, an increase of 2,636.37%. That is a compound annual growth rate of 44.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 3.08B | 21.66% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Parabilis Medicines | 3.50B |
| Viking Therapeutics | 3.48B |
| Celcuity | 3.38B |
| Tarsus Pharmaceuticals | 3.28B |
| Enliven Therapeutics | 3.24B |
| Dyne Therapeutics | 3.12B |
| IDEAYA Biosciences | 3.08B |
| Denali Therapeutics | 3.03B |